Thromboembolic complications of COVID-19

Mui, Leonora W.; Lau, Joe F.; Lee, Hwayoung K.

doi:10.1007/s10140-020-01868-0

Cited by 24 publications

(18 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Additionally, features of thrombotic microangiopathy have been demonstrated in 3.3% of 240 patients [ 52 ]. Supporting evidence for thrombotic complications includes rare cases of renal artery or renal vein thrombosis leading to renal infarction [ 61 ].…”

Section: Pathophysiological Mechanisms Of Kidney Involvement In the C...mentioning

confidence: 99%

Post-acute COVID-19 syndrome and kidney diseases: what do we know?

Çöpür

Berkkan

Basile³

et al. 2022

J Nephrol

View full text Add to dashboard Cite

COVID-19, a disease caused by a novel coronavirus (SARS-CoV-2), is a major global threat that has turned into a pandemic. Despite the emergence of multiple vaccination alternatives and developing therapeutic options, dramatic short- and long-term clinical outcomes have been recorded with more than 250 million infected people and over 5 million deaths as of November 2021. COVID-19 presents various respiratory, cardiovascular, neuropsychiatric, musculoskeletal and kidney features during the acute phase; nevertheless, renal involvement in the post-infection period has recently been emphasized. The present review aims to evaluate the growing literature on kidney involvement in the SARS-CoV-2 infection along with clinical features reported both in the acute phase of the infection and in the post-acute COVID-19 period by assessing potential pathophysiological frameworks explaining such conditions. Chronic kidney disease and development of acute kidney injury (AKI) in the course of initial hospitalization are associated with high mortality and morbidity rates. Moreover, growing evidence suggests a decline in renal function in the 6-to-12-month follow-up period even in patients without any signs of AKI during the acute phase. Despite such concerns there are no guidelines regulating the follow-up period or therapeutic alternatives for such patient population. In conclusion, the burden of COVID-19 on the kidney is yet to be determined. Future prospective large scale studies are needed with long follow-up periods assessing kidney involvement via multiple parameters such as biopsy studies, urinalysis, measurement of serum creatinine and cystatin C, directly measured glomerular filtration rate, and assessment of tubular function via urinary β 2 -microglobulin measurements. Graphical abstract

show abstract

Section: Pathophysiological Mechanisms Of Kidney Involvement In the C...mentioning

confidence: 99%

Post-acute COVID-19 syndrome and kidney diseases: what do we know?

Çöpür

Berkkan

Basile³

et al. 2022

J Nephrol

View full text Add to dashboard Cite

show abstract

“…Pulmonary embolisms, strokes, right ventricular thromboses, aortic thromboses, and kidney-related macrovascular events have all been documented in patients with COVID-19. 88 Renal artery thrombosis and renal vein thrombosis have both been documented, including cases with associated renal infarction; however, these are likely rare events. [88][89][90][91][92]…”

Section: Micro or Macrovascular Injury/endothelial Activation Contributing To Ckd Riskmentioning

confidence: 99%

“…88 Renal artery thrombosis and renal vein thrombosis have both been documented, including cases with associated renal infarction; however, these are likely rare events. [88][89][90][91][92]…”

Section: Micro or Macrovascular Injury/endothelial Activation Contributing To Ckd Riskmentioning

confidence: 99%

COVID-19 Survival and its impact on chronic kidney disease

Long

Strohbehn

Sawtell

et al. 2022

Translational Research

View full text Add to dashboard Cite

“…Both arterial and venous thromboembolism is common in patients with severe COVID-19, and thrombosis has been observed in the lungs, heart, kidneys, and brain [4] , [5] . Thrombosis in the vasculature arises from endothelial injury leading to excessive inflammation, platelet activation, and stasis [6] . These manifestations can be classified as an affliction of the endothelium, which serves as one unifying hypothesis in understanding COVID-19 [7] , [8] .…”

Section: Introductionmentioning

confidence: 99%